Discontinued — last reported Q2 '21
ResMed Loss Contingency Accrual remained flat by 0.0% to $800.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.3%, from $700.00K to $800.00K. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests higher legal or operational risk, while a decrease may indicate the resolution of past contingencies.
This represents the estimated liability for potential losses from legal proceedings, environmental claims, or other unce...
Standard accounting practice; peers report this based on their specific legal and environmental exposure profiles.
other_loss_contingency_accrual_at_carrying_value| Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $800.00K | $800.00K | $700.00K | $700.00K | $700.00K | $700.00K | $800.00K | $800.00K |
| QoQ Change | — | +0.0% | -12.5% | +0.0% | +0.0% | +0.0% | +14.3% | +0.0% |
| YoY Change | — | — | — | — | -12.5% | -12.5% | +14.3% | +14.3% |